At its meeting on June 10, 2025, the Board of Directors of Génome Québec approved the appointment of three distinguished individuals recognized for their expertise and commitment to research and innovation:
Amélie Quesnel-Vallée is the Inaugural Chair and Professor at McGill, specializing in equity, ethics, and health policy. She founded the McGill Observatory on Health and Social Services Reforms and the international consortium CAnD3. Her research on policies and social health inequalities has earned multiple awards, including two Fulbright distinctions. A former board member of the Canadian Institutes of Health Research, she has held key leadership roles and is frequently featured in major media for her expertise.
Ian Rae is President and CEO of Aptum and founder of CloudOps and cloud.ca, leading cloud computing innovation in Canada. He has held executive roles in technology and engineering and is active as an advisor and angel investor in the startup community. Mr. Rae serves on the boards of Air Transat, the Canadian Council of Innovators, and the Canadian Digital Governance Council. He holds a B.Sc. in evolutionary genetics from McGill University.
Dr. Mounia Azzi is a strategic life sciences consultant with over 20 years of experience bridging research, industry, and seed capital. She has held leadership roles at adMare BioInnovations, Nexelis, CQDM, and the NEOMED Institute. With a PhD in neuroscience and postdoctoral training at Université de Montréal, she now leverages her extensive Québec and international network to support life sciences organizations and entrepreneurs in their development, valorization, and financing strategies.
“We are delighted to welcome Ms. Azzi, Mr. Rae, and Dr. Quesnel-Vallée to our Board of Directors. Their diverse experience and commitment to advancing science and innovation will play a key role in guiding Génome Québec’s actions in the years ahead,” said Anie Perrault, Chair of the Board of Directors of Génome Québec.
These appointments reflect Génome Québec’s commitment to leveraging leaders with complementary expertise to advance its mission: to catalyze the development and excellence of genomics research, its integration, and its democratization.